HCW Biologics Inc (HCWB) recently have taken one step ahead with the beta value of 0.78

Witnessing the stock’s movement on the chart, on Thursday, HCW Biologics Inc (NASDAQ: HCWB) set off with pace as it heaved 0.19% to $0.43, before settling in for the price of $0.43 at the close. Taking a more long-term approach, HCWB posted a 52-week range of $0.21-$2.52.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -39.43%. Meanwhile, its Annual Earning per share during the time was -34.57%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.57%. This publicly-traded company’s shares outstanding now amounts to $37.82 million, simultaneously with a float of $19.75 million. The organization now has a market capitalization sitting at $16.25 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4139, while the 200-day Moving Average is $0.6537.

HCW Biologics Inc (HCWB) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. HCW Biologics Inc’s current insider ownership accounts for 47.77%, in contrast to 8.10% institutional ownership.

HCW Biologics Inc (HCWB) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

HCW Biologics Inc’s EPS increase for this current 12-month fiscal period is 18.57% and is forecasted to reach -0.50 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.29% through the next 5 years, which can be compared against the -34.57% growth it accomplished over the previous five years trading on the market.

HCW Biologics Inc (NASDAQ: HCWB) Trading Performance Indicators

Let’s observe the current performance indicators for HCW Biologics Inc (HCWB). It’s Quick Ratio in the last reported quarter now stands at 0.07. The Stock has managed to achieve an average true range (ATR) of 0.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.64.

In the same vein, HCWB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.00, a figure that is expected to reach 0.09 in the next quarter, and analysts are predicting that it will be -0.50 at the market close of one year from today.

Technical Analysis of HCW Biologics Inc (HCWB)

Going through the that latest performance of [HCW Biologics Inc, HCWB]. Its last 5-days volume of 71.68 million indicated improvement to the volume of 15.14 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 31.37% While, its Average True Range was 0.1272.

Raw Stochastic average of HCW Biologics Inc (HCWB) in the period of the previous 100 days is set at 9.49%, which indicates a major fall in contrast to 26.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 384.84% that was higher than 296.01% volatility it exhibited in the past 100-days period.